ABSTRACT Combinations of natural products have been used as important sources of disease treatments. Existing databases contain information about prescriptions, herbs, and compounds and their relationships with phenotypes, but they do not have information on the use of combinations of natural product compounds. In this paper, we identified large-scale associations between natural product combinations and phenotypes by applying an association rule mining technique to integrated information on herbal medicine, combination drugs, functional foods, molecular compounds, and target genes. The rationale behind this approach is that natural products commonly found in medicinal multicomponent mixtures have statistically significant associations with the therapeutic effects of the multicomponent mixtures. Based on a molecular network analysis and an external literature validation, we show that the inferred associations are valuable information for identifying medicinal combinations of natural products since they have statistically significant closeness proximity in the molecular layer and have much experimental evidence. All results are available through the workbench site at http://biosoft.kaist.ac.kr/coconut to facilitate the investigation of the medicinal use of natural products and their combinations.
I. INTRODUCTION
Natural products and their mixtures have been used as a valuable source of medicinal agents, and many modern drugs are still derived from natural products [1] , [2] . According to a previous review, 49% of approved cancer drugs are based on natural products, while only 25% are synthetic drugs [3] . Moreover, approximately 70-80% of the world's population depends on herbal sources for their primary health care [4] - [6] .
Combination therapy is gaining attention for overcoming the critical issues of single drug treatments, such as acquired resistance and side effects [7] - [9] . Recently, several combinations of natural products with various synergies were found in herbal medicines [10] - [12] , which indicates that combinations of natural products can be used as a valuable source for combination therapy. Therefore, a better understanding of natural product combinations, including their sources, efficacy and molecular mechanisms, based on accumulated knowledge is essential to identify new drug combinations.
There are several ongoing efforts to gather information on natural products. Herbal medicine databases, such as TCMID, TCM@Taiwan, HIT, TM-MC and PharmDB-K, were established to provide information about prescriptions, herbs, compounds and their relationships [13] - [17] . NPACT, NutriChem, MAPS and SuperNatural provide bioactivity and target information about natural products [18] - [21] . However, these databases rarely consider combinations of natural products. Although DCDB covers various types of information on combination drugs, it lacks information on natural products and their combinations since most compounds are small molecules [22] . Therefore, a database containing the association information between natural product combinations and phenotypes will benefit the discovery of potential therapeutic compound combinations. However, there is no database dedicated to the analysis of the potential effects of natural product combinations.
In this study, we developed an innovative database named Compound Combination-Oriented Natural Product Database with Unified Terminology (COCONUT), which contains associations between natural product combinations and phenotypes inferred from heterogeneous sources regarding herbal medicine, drug combinations, functional foods, molecular compounds and target gene information. Our fundamental hypothesis is that the natural product compounds commonly found in medicinal multicomponent mixtures for treating the phenotype are more related to the phenotype than are other compounds. Therefore, an association rule mining technique was applied to find frequent patterns between natural product combinations and phenotypes from medicinal multicomponent mixtures. Inferred associations were evaluated based on molecular network analysis and external literature. We confirmed that inferred associations have a statistically significant proximity in the molecular layer and cover the large number of results that have been reported in previous work. All integrated and inferred data of COCONUT are available through the workbench site at http://biosoft.kaist.ac.kr/coconut.
II. MATERIALS AND METHODS

A. DATA SOURCES
Korean, Chinese and Japanese herbal medicine information on prescriptions, herbs and compounds was collected from KTKP [23] , TCMID [13] and Kampo [24] , respectively. Food and its compound composition information was collected from FooDB [25] . Drug information was acquired from DrugBank [26] , and combination drug information was extracted from DCDB [22] . Functional food information was collected from the BFN database [27] .
Furthermore, compound-phenotype associations were collected from DrugBank, CTD [28] , ClinicalTrials.gov [29] and SIDER [30] . Compound-gene associations were collected from DrugBank, DCDB, CTD, TTD [31] , BindingDB [32] , MATADOR [33] and STITCH [34] . Gene-phenotype associations were collected from CTD. Additionally, we collected protein-protein interaction (PPI) network data from BioGrid [35] and pathway data from KEGG [36] , which are used to investigate the effects of natural products on the molecular layer. License and availability information of the source databases is described in Table 1 .
B. DATA INTEGRATION PROCESS
The goal of this study is finding the frequent patterns between natural product combinations and phenotypes from composition and efficacy information of medicinal multicomponent mixtures. To do this, we constructed a database for integrating the comprehensive information about natural products with eight major data entities: prescription, functional food, combination drug, herb, compound, compound property, gene and phenotype. The database included 13 relationships among the data entities, such as composition and functional information of the medicinal materials or associations among compounds, phenotypes and genes. The detailed schema of COCONUT is shown in Fig. 1 .
To store the data in a systematic manner, we integrated the information from heterogeneous sources into a standard format and structured the efficacy information. The construction procedure consists of following four steps (Fig. 2 ).
1) TERMINOLOGY UNIFICATION
In the terminology unification step, each entity instance is mapped to the corresponding international identifiers to resolve duplicate instances and to enhance interoperability VOLUME 6, 2018 FIGURE 1. Database schema of COCONUT. There are eight major dataentities: prescription, functional food, combination drug, herb, compound, compound property, gene, and phenotype. The 13 types of relationships among the major data entities are recorded.
with other public databases (Fig. 2a) . Herbs were mapped to NCBI taxonomy ID, a curated classification for the organisms, based on scientific names [37] . For compounds, the ChemSpider API was used to find the international chemical identifier (InChI) [38] . Genes were mapped to Entrez gene ID with the DAVID gene ID conversion tool (DICT) [39] . Because most source databases have different types of gene information, such as gene symbols, UNIPROT ID and ENSEMBL ID, DICT was used to map the various types of gene ID to Entrez gene ID. Additionally, we identified combination drugs and functional foods with DCDB ID and brand name, respectively.
2) EXTRACTION OF BIOMEDICAL TERMS
In many databases, a large amount of efficacy and indication information is described in the narrative text. Thus, there is a problem that when a user searches for entity instances associated with a particular phenotype, all words of the narrative text should be retrieved. To extract phenotype-related terms from the narrative text, we employed MetaMap, a text-mining tool that maps biomedical text to the Unified Medical Language System (UMLS) concepts (Fig. 2b) [40] - [43] . Compared to other named entity recognition (NER) tools, MetaMap is strong in the validity and customization aspects. Many previous studies have demonstrated that MetaMap has applicability and reliability in the field of clinical and biomedical forms [44] - [46] . Additionally, MetaMap can be customized in the configuration layer [47] , [48] . To avoid ambiguous results, we used MetaMap's word-sense disambiguation (WSD) module that identifies reliable words based on the context of a sentence. Depending on the characteristics of sources, we used the term processing option that recognizes input text as one phrase. Finally, UMLS concepts for biomedical text can be obtained from MetaMap.
UMLS currently integrates over 730,000 biomedical concepts from more than fifty biomedical vocabularies [41] . All concepts are categorized into 133 predefined semantic types. For each concept, UMLS editors assigned one or several semantic types. In this study, we tried to identify phenotype-related terms that could fully describe the efficacy and indications of medicinal materials. Based on the MetaMap results and definitions of semantic types, 20 semantic types were selected through manual curation to represent the phenotypes related to diseases or symptoms (Table 2) . Then, we applied MetaMap to the narrative text and extracted phenotype-related terms using the selected semantic types as filtering criteria.
3) DUPLICATION RESOLUTION
Because the data were collected from multiple sources, duplicate instances exist. Therefore, duplicate instances of the combination drug, functional food, herb, compound and gene entities are detected by comparing the international identifiers. We then merged duplicate instances into one instance and registered it with source references (Fig. 2c) . For example, information about Melia azedarach used as an herb was collected from the KTKP and TCMID databases. Based on the NCBI taxonomy ID, we determined whether the herb information gathered from each resource is the same. If they are the same, the function and toxicity information are integrated and the reference for each information item is registered. However, prescriptions are hard to distinguish by their general name only because they contain different herb compositions, even though they have the same general name. Therefore, even if instances of a prescription entity have the same general name, they are considered as different instances.
4) CALCULATION OF CHEMICAL PROPERTIES
Chemical properties of compounds were calculated for producing physiological effects (Fig. 2d) . Physiological effects include human intestinal absorption (HIA), Caco-2 permeability, blood-brain barrier (BBB), and Lipinski's rule of five (RO5). Based on the physiological effects, we can investigate whether natural products are orally bio-available, drug available or effective on certain tissues. For example, in vivo absorption of natural products across the gut wall can be estimated based on the Caco-2 permeability. In this study, physiological effects are calculated based on the physicochemical properties, such as molecular weight, AlogP, hydrogen-bond donors, hydrogen-bond acceptors and rotatable bond count. HIA and BBB values are calculated with Shen's method [49] , while Caco-2 permeability is calculated using Pham's method [50] . RO5 are calculated with the CDK Descriptor Calculator [51] . Based on the physiological effects, we can analyze various functional activities of the natural products on the human body.
C. A DATA-DRIVEN ANALYSIS FOR IDENTIFYING MEDICINAL COMBINATIONS OF NATURAL PRODUCTS
Our fundamental hypothesis is that compounds commonly found in herbs, functional foods or combination drugs used to treat or prevent the phenotype are more related to the phenotype, compared to other compounds. To extract associations between natural product combinations and phenotypes, we applied an association rule mining analysis. The analysis procedure consists of the following three steps (Fig. 3 ).
1) GENERATING DATASET FOR ASSOCIATION RULE MINING
To apply association rule mining, we first constructed compound set profiles for each phenotype that contain compound composition and phenotype information of 4,370 herbs, 1,322 functional foods and 1,605 combination drugs (Fig. 3a) . In the compound set profile, compounds are set of items and a phenotype is a class label. Each attribute has a value of 1 or 0; a '1' is assigned if the multicomponent mixture contains that attribute, otherwise '0' is assigned. To determine how many herbs, combination drugs and functional foods are related to phenotypes and how many compounds are contained in each entity, we examined the distribution of the number of phenotypes and the distribution of the number of compounds for each entity (Fig. 4) .
2) APPLYING ASSOCIATION RULE MINING
With current biological knowledge, it is impossible to determine the dependency between natural products in medicinal materials or the linearity of relationships between combinations of natural products and phenotype. Association rule mining has the distinct advantage of being able to directly model based on conditional probabilities, avoiding the linearity assumptions underlying many classical supervised classification, regression and ranking methods [52] - [54] . Moreover, association rule mining helps avoid problems with the curse of dimensionality [55] , [56] . In this study, medicinal materials contain 35,741 unique natural compounds. If we consider all possible combinations of natural compounds, then there are 2 35 ,741 possibilities -a high curse of dimensionality. In practice, however, most of the combination drugs consist of two compounds [22] . Association rule mining makes predictions from subsets of coexisting items, which makes the estimation much easier. Moreover, 'lutein → fever' could be much easier to analyze than 'lutein, quercetin, biotin, spermine, etc. → fever'. As molecular mechanisms between natural compounds and phenotypes are very complex, it is important to simplify the prediction results. One other advantage of association rule mining is high-level interpretability, which enables intuitive explanations for the reasons why the inferred result occurred [57] , [58] . It is useful to support further investigation of the inferred results in the functional food or drug development field.
3) STATISTICAL PARAMETERS OF ASSOCIATION RULES
A rule generated by association rule mining has the form of 'antecedent → consequent', where the antecedent is the combination of natural product compounds and the consequent is the target phenotype (Fig. 3b) . For all association rules, we measured the significance with support, confidence and lift. The support value represents the ratio of instances containing both antecedent and consequent item-sets of the rule over the whole instances, which indicates the number of evidence items for the rule. Because the number of whole instances is constant, the support value is not expressed as a ratio, but rather is expressed as the number of instances containing both antecedent and consequent item-sets. For example, the support value of 10 means that there are ten medicinal materials containing the natural product combination that have effects on the target phenotype, as evidence of the rule. The confidence value is the ratio of instances containing both antecedent and consequent item-sets over the instances containing antecedent item-sets, which represents how often the rule is found to be true. For example, a confidence value of 0.5 means that the half of the medicinal materials containing the natural product combination have effects on the target phenotype. The lift value is the confidence value normalized by the number of instances containing consequent item-sets, which indicates the independence between the antecedent and consequent item-sets. For example, a lift value of 1 means that the natural product combination and target phenotype are completely independent, and a lift value of 2 means that the natural product combination is two times more dependent on target phenotype than random natural product combination.
4) ADDITIONAL INFORMATION FOR INFERRED ASSOCIATION RULES
We provide additional information of inferred associations to support further investigation on the inferred combinations of natural products (Fig. 3c) . Compound properties and a list of sources of natural products are provided by searching the integrated information in COCONUT. For the target analysis, we adopted Dijkstra's algorithm to find the shortest paths between compound targets and phenotype-associated genes in the PPI network and signaling pathways [47] . All information related to inferred associations is visualized in the form of a network. We structured the composition and functional information of the medicinal multicomponent mixtures as relationships between the entities. For example, the herbal composition of prescriptions is stored as 140,690 relationships, and the functional information of prescriptions is stored as 103,085 relationships. To support further investigation at the molecular level, we stored relationships among chemical compounds, phenotypes and genes (Table 4) . 
III. RESULTS
B. ASSCIATIONS BETWEEN NATURAL PRODUCTS AND PHENOTYPES
The core data of COCONUT consists of 899,476 associations between 23,036 natural product combinations and 376 target phenotypes. For all associations, we provide support, confidence and lift values as the significance scores (Table 5) . Furthermore, we examined oral bioavailability and molecular target paths to provide additional evidence, which helps us to select drug candidates among inferred associations (Table 6) . For oral bioavailability, we check whether the natural products in inferred associations satisfy RO5. For all associations, 496 natural products and 266,263 natural product combinations satisfied the RO5. Next, we check whether natural product combinations are associated with the target phenotype on the molecular network. For 193,332 associations of 96 phenotypes, 26,825 associations have direct or indirect connections between compound targets and phenotype-associated genes. For example, the combination of L-(+)-arginine and biotin was inferred to be associated with diarrhea. This association is considered to be an important candidate because it is given a high confidence and lift values (conf. = 1.0 and lift = 23.63). Further analysis of COCONUT revealed that both L-(+)-arginine and biotin satisfy RO5. Moreover, we found that many of both targets of L-(+)-arginine and biotin are connected to the diarrhea-associated gene from the shortest path analysis (Fig. 5) . Based on this approach, the COCONUT database can be used as a preliminary tool to identify the medicinal compound combination candidates from a large number of natural products.
C. PERFORMANCE EVALUATION 1) ROBUSTNESS TESTING
To verify whether inferred associations were not vulnerable with respect to variations of the dataset, we examined their robustness among different datasets with 4-fold cross-validation (Table 7) . For this, the compound set profiles were divided into four folds. The instances having a therapeutic effect on the target phenotype were equally divided in each fold. Then, each three-fold was used to infer the associations between natural product combinations and target phenotype, while the remaining one was used to evaluate the robustness of the inferred associations. The robustness score of an association rule is defined as n/N , where N is the number of instances having the natural product combination in the test set, and n is the number of instances having the natural product combination with effects on the target phenotype in the test set. Consequently, the robustness score measures whether the inferred associations have a robust explanatory power for known indications of medicinal materials in the data set. For the target phenotype, associations with confidence values higher than 0.7 were selected. Then, the robustness of the target phenotype was calculated as the average robustness score of the selected associations. As a result, the average robustness (r avg = 0.733) for 41 target phenotypes was relatively high, considering the proportion of compounds shared by both test and training sets (22%). This indicates that the inferred associations are robust in the data set.
2) EVALUATION BASED ON MOLECULAR NETWORK ANALYSIS
To evaluate the significance scores of the inferred associations, we selected the top 5% highest scoring associations and the bottom 5% lowest scoring associations based on the support, confidence and lift, respectively. In the previous study, the relative proximity (z c ) was proposed to quantify the relationship between compounds and phenotype genes in the molecular network [59] . They found that a compound tends to have a phenotype when compound targets and phenotypeassociated genes are closely located on a molecular network. For each compound-phenotype pair, they compare the distance between compound targets and phenotype-associated genes to the random expectation distances, which were calculated by randomly selecting the phenotype-associated genes within the molecular network. This study also found that closest measure, which calculated the distance based on the average shortest path between the compound targets and the nearest phenotype-associated gene, showed the best performance in predicting drug efficacy, when compared with the shortest, kernel, centre and separation measures. Therefore, in this study, the relative proximity using the closest measure was used to assess the prediction results according to the significance scores. We compared the relative proximity values of the selected six association sets and the verified drug-phenotype set collected from DrugBank [26] . The molecular network was constructed by using the PPI information collected from BioGird [35] (Fig. 6) .
The average relative proximity values of all sets are lower than zero, which means that compound targets and phenotype-associated genes are closer in the molecular network than randomly selected gene sets (avg.z c > 0). Moreover, the average relative proximity values of associations having high support, confidence and lift values (avg. z c = −0.71, −0.87 and -0.91, respectively) are comparable to the verified drug-phenotype set (avg. z c = −1.54). For associations selected by confidence value, the average relative proximity of a high-scoring set (avg. z c = −0.87) is higher than the low-scoring set (avg. z c = −0.38). Next, we performed a Mann-Whitney U test and calculated the corresponding p-values to check the significant difference between the high-scoring and low-scoring sets [60] . A p-value of the Mann-Whitney U test lower than 0.05 was considered statistically significant. From the result, we found that the difference between high-and low-scoring sets is statistically significant (p-value = 2.1 × 10 −10 ). Similarly, for associations selected by the lift value, the average relative proximity of high-scoring sets (avg. z c = −0.91) is higher than the low-scoring sets (avg. z c = −0.37), and this difference is also significant (p-value = 2.8 × 10 −9 ). These observations indicate that the associations with high confidence or lift imply significant interplay between compound targets and phenotype-associated genes. However, for associations selected by the support value, there is no significance difference (p-value = 0.76) between high-and low-scoring sets (avg. z c = −0.71 and −0.69, respectively).
3) EVALUATION BASED ON EXTERNAL LITERATURE
In this study, the associations between natural products and phenotypes were inferred from the known efficacy of medicinal multicomponent mixtures and their chemical compositions. In other words, PubMed information for direct evidence between natural products and the phenotypes was not used during the inference process. Therefore, to evaluate the inferred associations, we employed PubMed as the independent external dataset and searched literature evidence containing the inferred associations. Using the selected six association sets described in the previous section, we checked whether the associations with high support, confidence and lift values have more evidence in the external literature than the associations with low values. To do this, co-occurrences (n c ) of compounds and a phenotype in each association were counted in 13,200,786 PubMed abstracts that were published from 1950 to 2013 [61] . For associations selected by the confidence value, the average co-occurrence count of the high-scoring sets (n c = 39.17) is 6.9 times larger than the low-scoring sets (n c = 5.38). Similarly, for associations selected by the lift value, the average co-occurrence count of the high-scoring sets (n c = 33.7) is 10.9 times larger than the low-scoring sets (n c = 3.08). These results show that confidence and lift can be used as parameters for identifying significant associations (Table 8) . We also performed a Mann-Whitney U test and calculated the corresponding p-values to check the significant difference of literature evidence between the high-and low-scoring sets. Co-occurrence values do not take the frequencies of individual terms into account; they were normalized as the Jaccard index (JI) about the frequencies of individual terms. For the association sets selected by the confidence and lift values, the average Jaccard index values of high-scoring sets (JI = 1.89 × 10 −3 and 3.04 × 10 −3 , respectively) were markedly higher than those of the low-scoring sets (JI = 1.15 × 10 −4 and 1.03 × 10 −4 , respectively). Furthermore, we investigated the number of significant associations (n f ) by performing Fisher's exact test (p-value < 0.001). Fisher's exact test can assess the null hypothesis of independence by applying the hypergeometric distribution of the numbers in a contingency table [62] . To obtain a Fisher's test value of each association, the number of PubMed abstracts was counted based on whether they included the compound and whether they included the target phenotype. For association sets selected by the confidence and lift, the numbers of significant associations of the high-scoring sets (n f = 20 and 22, respectively) were markedly larger than those of the low-scoring sets (n f = 2 and 4, respectively). Additionally, the p-values of the Mann-Whitney U test indicated that the difference in documented evidence between the high-and low-scoring sets was significant.
However, for association sets selected by the support value, there was no significant difference between high-scoring and VOLUME 6, 2018 low-scoring sets in the average co-occurrence count, average Jaccard index and the number of significant associations based on Fisher's exact test. This result could be due to the characteristics of support, which only indicate the appearance of the associations as mentioned in the former section.
In conclusion, we suggest that inferred associations with higher significance scores can be used as potential therapeutic compound combinations for future studies.
D. WEB INTERFACE AND USE CASE
We implemented a workbench website for the COCONUT database to provide two services. First, the search service enables exploring comprehensive information about natural products (Fig. 7) . The database search service can be accessed through the 'Search' tab on the main page (Fig. 7a) . After selecting the entity type, users can search instances by typing query keywords or selecting an instance in the alphabetic table (Fig. 7b) . Detailed information of the query instance is represented in the search result (Fig. 7c) . The information on related entities is also provided in the association table with source references. Therefore, users can know the source for the information of interest. The related entities can be investigated through hyperlinks in the association table or the visualized network (Fig. 7d) . As an example, Panax ginseng can be queried in the 'Herb' tab of the search service. From the result, users can investigate that Panax ginseng has been used in the treatment of diarrhea, impotence and intestinal pain, and it is composed of various natural product compounds, such as ginsenoyne I, lutein and trifolin. combinations and phenotypes (Fig. 8) . The analysis service can be accessed through the 'Analysis' tab on the main page (Fig. 8a) . The user can inquire about natural product combinations for a natural product or phenotype of interest. Like the database search, users can search for information by keyword or the alphabetic table (Fig. 8b) . In the analysis result, a list of associations between natural product combinations and phenotype is represented along with statistical significance parameters, such as support, confidence and lift (Fig. 8c) . By adjusting the threshold of each parameter, users can focus on reliable associations. Moreover, users can analyze the association of interest more minutely in terms of pharmacokinetic property, target analysis, related herbs and network visualization (Fig. 8d) . For example, fever can be queried in the 'Phenotype' tab of the analysis service. Associations between natural product combinations and fever are represented as query results. By sorting the associations with a confidence value, users can observe statistically significant associations, such as 'Magnoflorine, Columbamine → Fever'. Additional information on the association can be obtained in the bottom panel. From the PK property tab, users can find that both magnoflorine and columbamine satisfy RO5. All shortest paths between target genes and phenotype-associated genes in a molecular network, such as CDH5 (columbamine target gene) -CTNNA1 -UBC -HTR1A (fever-associated gene), can be investigated using the target analysis tab. Furthermore, users can examine the list of herbs that contain both magnoflorine and columbamine. Entities, including herbs, combination drugs, functional foods and genes, related to each compound are visualized through a network.
IV. DISCUSSION
Natural products and their combinations have distinctive advantages in drug and functional food discovery. Since they are secondary metabolites of other organisms, they are more likely to have bioactivities, and they present unique structural diversities from which we can discover novel therapeutic compounds [63] , [64] . Therefore, a better understanding of the natural products through scientific analysis will provide new insights into the use of natural products as medicine.
Our study has strengths in two aspects. First, the COCONUT database provides comprehensive information about natural products in a structured and standard form. Compared to existing databases such as KTKP, TCMID and KAMPO, using a simple query, researchers can obtain the prescription, herb, compound and gene information associated with a particular phenotype because all information in COCONUT is structured. This process allows researchers to easily collect data when designing in vitro and in silico experiments for specific natural products or phenotypes. In addition, COCONUT provides standardized information; thus, it can minimize confusion or misreading of information and improve interoperability when researchers use COCONUT with other external databases. For example, when researchers identify medicinal compounds from Panax ginseng, they could use COCONUT in an initial stage of the experiment to collect comprehensive information about the Panax ginseng with standardized international identifiers, such as the known efficacy, the natural products they contain, and the associated genes (Table 9 ). Second, we provide promising candidates of medicinal combinations of natural products to support combination drug or functional food discovery studies. Most of the previous studies on finding medicinal agents from natural products were performed by in vitro assessment. However, large-scale experiments are required for a large number of natural products and their combinations. Therefore, in silico approaches have been proposed, primarily based on molecular analysis. However, many natural products do not have molecular structural information, and their target protein information remains mostly unknown. More importantly, the conventional in silico methods are aimed at investigating single agents. Hence, there is no method to predict the medicinal combinations of natural products. Our approach is different from previous in silico methods in that it finds combination patterns of natural products from the accumulated medicinal materials using a data-driven approach. In the performance evaluation, we performed molecular network analysis. There is no goldstandard dataset for the therapeutic effects of combinations of natural products; thus, we investigate whether there is a significant relationship between the targets of the natural products and the phenotype-associated genes in the molecular network. From the results, we confirmed that the inferred associations with high scores between natural products and phenotypes have significant associations in the molecular network. We also found that the high-scoring associations have more evidence in the external literature. This indicates that the proposed data-driven analysis enabled us to identify medicinal candidate effects of natural products. Our results can help researchers conduct further in vitro and in silico experiments by filtering natural products or herbs from a large number of candidates. For example, when researchers study the effects of Panax ginseng on fever, they can utilize our results to find promising combinations of natural products found in Panax ginseng (Table 10) . Additionally, the information of chemical properties and path analysis in the COCONUT database helps to select the specific candidates before they carry out further studies.
There are some additional considerations for improving our work. First, although this study analyzed the shortest path between the known natural product targets and the phenotype associated genes, the results are insufficient due to the lack of molecular information. However, this limitation can be resolved with further experiments and improved techniques. We expect that more accurate predictions can be made in additional in silico studies. For example, previous studies have demonstrated that associations between compounds and targets can be predicted by investigating propagated compound effects on the disease genes in a molecular network [65] , [66] . Based on this approach, researchers can estimate potential mechanism of actions of natural product combinations by calculating overlap effect in a molecular network based on COCONUT information. Second, our database contains associations between medicinal materials and phenotypes, but there is no specification about the types of associations, such as cause, treat or prevent. To overcome the limitation, we will improve the text mining method to extract the detailed association types. Finally, the database volume will be periodically expanded by integrating information from various sources. At present, COCONUT mainly focused on herbal medicine information of northeastern Asia. Therefore, information can be biased toward a particular region or country. In the future, we will add herbal medicine information from various regions, such as India, Australia and America. Additionally, we are planning to include information not only from conventional databases but also from biomedical literature and experiment results. With the updated information, we will develop and apply various methods for more reliable prediction of the medicinal combinations of natural products. Ultimately, we believe that COCONUT will be used as a valuable resource in eliminating the bottlenecks in the current natural product research by combining with various biological information sources.
V. CONCLUSION
Natural products have been used as important sources of herbal medicine and modern drug development. COCONUT is useful for investigating natural products and their corresponding information, such as major sources, activities and efficacies. More importantly, COCONUT enables us to perform large-scale analysis on the medicinal use of natural product combinations. We believe that COCONUT will be a major bioinformatics resource for polypharmacology studies and will be of interest to pharmacologists, toxicologists and computational biologists by providing clues for the prediction of medicinal combinations from a wide range of natural products.
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